Results 71 to 80 of about 28,929 (194)

ACTH suppression and adverse effects of cabergoline in horses with pituitary pars intermedia dysfunction

Equine Veterinary Education, Volume 38, Issue 9, Page e622-e630, September 2026.
Summary Background The diagnosis and management of pituitary pars intermedia dysfunction (PPID) in horses includes evaluating abnormal plasma concentrations of adrenocorticotrophic hormone (ACTH). Treatment commonly includes the oral dopamine agonist pergolide mesylate, which suppresses the pathologic overproduction of ACTH.
A. Bracken, H. Tyra, M. Vetter, K. Kiger, S. Rao, L. Bass   +5 more
wiley   +1 more source

Latent Class Analysis of Negative Emotion Subtypes and Their Association With Quality of Life in Patients With Pituitary Neuroendocrine Tumors

Brain and Behavior, Volume 16, Issue 8, August 2026.
ABSTRACT Introduction Pituitary neuroendocrine tumors (PitNETs) account for up to 15% of intracranial tumors. Patients commonly present with various emotional and cognitive impairments, including a high prevalence of anxiety and depression. Therefore, this study aimed to identify the latent subtypes of negative emotions in patients with PitNETs and ...
Lei Jin, FangYuan Yao, JinHua Yang, Jing Gong, JingHua Sheng, ShuYa Chen, Li Ji, Chen Wei   +7 more
wiley   +1 more source

Progress on diagnosis and treatment of pituitary adenoma in children

Chinese Journal of Contemporary Neurology and Neurosurgery
Pituitary adenoma is a benign intracranial tumor, commonly found in adults and occasionally in children. Pituitary adenoma is classified into secretory and non-secretory adenoma based on whether there is abnormal hormone secretion.
WANG Chuan-wei, DU Guo-ran, WANG Yan-zhao, ZHU Shao-lei, ZHANG Bin, GONG Jie   +5 more
doaj   +1 more source

Secondary Adrenal Insufficiency Presenting With Severe Hyponatremia in an Elderly Patient With Primary Aldosteronism Suggesting Underlying Autonomous Cortisol Secretion

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Possible unrecognized cortisol autonomy in primary aldosteronism may suppress the hypothalamic–pituitary–adrenal axis. Under physiological stress, this may contribute to secondary adrenal insufficiency and severe hyponatremia. Clinicians should consider adrenal insufficiency in patients with primary aldosteronism presenting with unexplained ...
Minami Toda, Shunsuke Takahashi, Hitomi Saito, Honami Mori, Yutaka Kuroda, Akito Maeshima   +5 more
wiley   +1 more source

siRNA-mediated silencing of bFGF gene inhibits the proliferation, migration, and invasion of human pituitary adenoma cells

Tumor Biology, 2017
Human pituitary adenoma is one of the most common intracranial tumors with an incidence as high as 16.7%. Recent evidence has hinted a relationship between growth factors of pituitary or hypothalamic origin and proliferation of human pituitary adenoma ...
Kai Zhou, Yan-Dong Fan, Serick Duysenbi, Peng-Fei Wu, Zhao-Hai Feng, Zheng Qian, Ting-Rong Zhang   +6 more
doaj   +1 more source

Olfactory‐Related Quality of Life After Endoscopic Transsphenoidal Surgery

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.
The QOD‐LQ, QOD‐VAS, and the “decreased sense of smell” item of the SNOT‐22, reflecting olfactory‐related quality of life (QOL) and subjective olfactory dysfunction, significantly deteriorated after EETSA in a substantial proportion of patients, even though psychophysical olfactory function was preserved.
Yeong Ju Lee, Jeong Heon Kim, Chang‐Ki Hong, Young‐Hoon Kim, Ji Heui Kim   +4 more
wiley   +1 more source

The Serum Testosterone Level in Male Patients Is Inversely Associated With Hypertension Incidence

The Journal of Clinical Hypertension, Volume 28, Issue 8, August 2026.
ABSTRACT Hypertension is a primary risk factor for cardiovascular diseases and all‐cause mortality. Testosterone, the most potent androgen in males, regulates reproduction, metabolism, and erythropoiesis. Hypertension incidence increases with age, whereas testosterone levels decline. Thus, we conducted a study to explore the association between the two
Huan‐dong Wu, Meng‐meng Dong, Biqi Zhang, Zao‐xian Xu, Jiangping Wu, Shen‐Jiang Hu   +5 more
wiley   +1 more source

Acromegaly with no pituitary adenoma and no evidence of ectopic source

Indian Journal of Endocrinology and Metabolism, 2011
More than 99% of patients with acromegaly harbor a growth hormone (GH) secreting pituitary adenoma. As the time from onset of signs/symptoms to diagnosis of acromegaly is long (symptom onset to diagnosis is often 4-10 years), pituitary adenomas that ...
Deepak Khandelwal, Rajesh Khadgawat, Amar Mukund, Ashish Suri   +3 more
doaj   +1 more source

Can acromegaly be controlled in all cases?

Journal of Neuroendocrinology, Volume 38, Issue 8, August 2026.
Abstract Acromegaly is a rare disease, due in most of the cases to a growth hormone (GH)‐secreting pituitary adenoma (PA), namely neuroendocrine tumour (PitNET). The treatment of patients with acromegaly is multimodal and multi‐step, including surgery, medical therapies, and radiotherapy.
Sabrina Chiloiro, Francesco Padovano Sorrentino, Alessandra Vicari, Antonella Giampietro, Pier Paolo Mattogno, Quintino Giorgio D'Alessandris, Rosalinda Calandrelli, Tommaso Tartaglione, Marco Gessi, Simona Gaudino, Laura De Marinis, Guido Rindi, Francesco Doglietto, Antonio Bianchi, Alfredo Pontecorvi   +14 more
wiley   +1 more source

Incidental pituitary adenomas

Neurosurgical Focus, 2011
Object Pituitary incidentalomas are a common finding with a poorly understood natural history. Over the last few decades, numerous studies have sought to decipher the optimal evaluation and treatment of these lesions.
Walavan Sivakumar, Roukoz Chamoun, Vinh Nguyen, William T. Couldwell, null Ph.D.   +4 more
openaire   +2 more sources